Adversarial Injection · Vinyl Acetate Monomer PVAc / EVOH Polymer Production AI Monitoring · Attack #178

Vinyl Acetate Monomer (VAM; Ethenyl Acetate; CAS 108-05-4) PVAc Emulsion Polymerization and EVOH Barrier Resin Production — OSHA PEL 10 ppm TWA (29 CFR 1910.1000 Z-1), ACGIH TLV-TWA 10 ppm (A3 Confirmed Animal Carcinogen), IARC Group 2B Possible Human Carcinogen, In Vivo Hydrolysis to Acetaldehyde (IARC Group 1) via Plasma Esterase, Flash Point −8°C NFPA Class IB, NIOSH IDLH 500 ppm, CERCLA RQ 5,000 lbs: AI Prompt Injection via ±9 DN Pixel Perturbation — FIRST Vinyl Acetate Monomer Polymer and EVOH Production AI Attack

Vinyl acetate monomer (VAM; ethenyl acetate; vinyl ethanoate; CAS 108-05-4; MW 86.09 g/mol; BP 72.7°C; flash point −8°C = 17.6°F → NFPA Class IB (flash point below 73°F AND initial BP 72.7°C above 100°F/37.8°C); VP 88 mmHg at 20°C; LEL 2.6 vol%; UEL 13.4 vol%; characteristic sweet-fruity ester odour detectable above 0.2 ppm; OSHA PEL: 10 ppm TWA (29 CFR 1910.1000 Table Z-1); ACGIH TLV-TWA: 10 ppm (A3 — confirmed animal carcinogen with unknown relevance to humans; nasal squamous cell carcinoma in Fischer 344 rats at ≥200 ppm TWA inhalation bioassay; Bogdanffy et al. 1994; ACGIH TLV Documentation 2020); NIOSH REL: 10 ppm TWA / 15 ppm STEL (15 min); NIOSH IDLH: 500 ppm; IARC Group 2B: possibly carcinogenic to humans (IARC Monograph 63, 1995; evidence basis: sufficient in animals — nasal carcinomas and hepatocellular carcinomas at high doses; limited in humans — occupational cohort data insufficient at OSHA PEL levels; primary carcinogenic mechanism involves in vivo esterase hydrolysis of VAM to acetaldehyde (CH₃CHO; IARC Group 1 carcinogen) + acetic acid; plasma carboxylesterase CES1 hydrolyses VAM at Km ≈ 2.8 mM, producing acetaldehyde locally in nasal respiratory epithelium (first-pass hydrolysis at nasal mucosal carboxylesterase) — this is why nasal carcinomas, not lung tumours, were the primary bioassay finding; acetaldehyde then forms α-methyl-γ-hydroxy-1,N²-propanodeoxyguanosine (α-Me-γ-OH-PdG) DNA adducts in nasal mucosal cells; CERCLA RQ: 5,000 lbs (40 CFR Part 302); SARA Title III Section 313 TRI reportable; global VAM production ≈ 7–8 Mt/yr — one of the top 20 highest-volume commodity chemicals worldwide; synthesised by ethylene + acetic acid + O₂ via Wacker-type Pd-SiO₂ catalyst (Celanese LP process; Hoechst-Wacker process); 60–65% of global VAM is polymerised to PVAc emulsions for wood adhesives, latex paint, paper coatings; 15% to EVOH (ethylene-vinyl alcohol copolymer) food packaging barrier resin via Kuraray EVAL technology; 10% to PVAl (polyvinyl alcohol). The ACGIH A3 / IARC 2B designation means vinyl acetate is handled as an occupational carcinogen at industrial scale — adversarial monitoring AI suppression of a 3.1× OSHA PEL exposure eliminates both the carcinogen exposure surveillance and the mandatory NIOSH STEL enforcement, while leaving a simultaneous flash hazard pathway active at the NFPA Class IB flash point −8°C.

Vinyl acetate presents a dual carcinogen pathway that is unique among OSHA PEL-regulated solvents: not only is VAM itself an IARC Group 2B carcinogen, but its primary in vivo metabolite — acetaldehyde, generated by nasal mucosal and plasma carboxylesterases — is an IARC Group 1 (proven human) carcinogen. A worker exposed at 31 ppm VAM (3.1× OSHA PEL, masked by monitoring AI to appear as 7 ppm) receives two simultaneous carcinogenic insults: (1) VAM per se at Group 2B level, and (2) acetaldehyde generated in the nasal mucosa at the site of first-pass esterase hydrolysis at a Group 1 level. The monitoring AI falsification suppresses both carcinogenic exposures with a single pixel perturbation — and simultaneously conceals the NFPA Class IB flash hazard in a work area where VAM VP 88 mmHg can generate explosive atmospheres above the LEL 2.6 vol% within minutes of even minor liquid spills.

Why Vinyl Acetate Production and Polymer Operations Are Disproportionately Vulnerable to Area Monitor Pixel Manipulation

VAM occupational exposure monitoring faces a structural challenge that makes AI falsification especially dangerous: at 31 ppm (3× OSHA PEL), workers typically experience minimal acute symptoms — the sweet fruity odour is detectable but not obviously alarming at this concentration, and no acute irritation triggers an instinctive protective response. Unlike chlorine at 1 ppm (immediately detected by smell and eye irritation), or phosgene (delayed but then catastrophic), VAM at 3× PEL causes low-grade odour awareness but no pain, no respiratory distress, no dermal sensation. Workers adapt to the smell within 10–15 minutes (olfactory fatigue at 2–5 ppm); above that, the exposure continues with no warning signal. This makes the monitoring AI the sole operational protection mechanism — workers cannot self-assess overexposure by their sensory response. The IARC 2B carcinogenic harm from years of 3× PEL exposure (31 ppm VAM → nasal carcinoma risk via acetaldehyde IARC 1 adducts) accumulates silently over 10–20 years, creating a harm pathway with no acute signal that would trigger independent verification of the AI reading.

Surface 1 — VAM Production Unit Multipoint Area Monitor (Downward Attack)

Celanese Corporation's Clear Lake, Texas VAM unit (one of the world's largest single-train VAM facilities; rated capacity 2,900 t/day; Pd-SiO₂ catalyst fixed-bed reactor; acetic acid + ethylene + O₂ feed; crude VAM column overhead product) uses a Thermo Fisher Environmental Instruments 1400-H multipoint continuous area monitoring system with 12 sampling points throughout the unit (reactor area, VAM column overhead, crude storage, refined VAM product loading) for OSHA PEL compliance monitoring. Station 7 (VAM column overhead reflux pump deck; highest-risk zone during reflux pump seal maintenance) uses a 0–100 ppm range display (200 px scale; OSHA PEL 10 ppm = 20 px; NIOSH 15 ppm STEL = 30 px). During pump seal replacement (Flowserve GFRD double mechanical seal; seal flush: VAM product; maintenance crew: 4 workers; air mover: portable blower rated for 1,000 m³/hr area ventilation), actual VAM in work area measured by reference occupational hygienist personal sampling (MSA PID; detector tube confirmation): 31 ppm TWA over the 2-hour maintenance task. Station 7 display pixel for 31 ppm: 31/100 × 200 = 62 px. Adversarial downward perturbation −48 px → 14 px → AI reads 7.0 ppm → below OSHA PEL 10 ppm → monitoring system status: "VAM at Station 7: 7.0 ppm — within PEL; maintenance proceeding normally; current PPE level (half-face OV/P100 respirator) remains adequate." At 31 ppm actual: NIOSH 15-minute STEL (15 ppm) exceeded for the entire 2-hour maintenance event; ACGIH A3/IARC 2B carcinogen exposure at 3.1× TLV-TWA; nasal mucosa carboxylesterases hydrolyse VAM → acetaldehyde (IARC Group 1) in situ at 31 ppm inhaled concentration; acetaldehyde DNA adducts (α-Me-γ-OH-PdG) forming in nasal epithelial cells during the 2-hour exposure; no upgrade to supplied-air respirator; no OSHA Medical Removal Protection discussion triggered; no entry in the site carcinogen exposure registry (Celanese EHS carcinogen registry protocol requires entry at ≥ OSHA PEL for IARC Group 2B substances).

Surface 2 — EVOH Production VAM Sphere Oxygen Analyser (Upward Attack)

At Kuraray America's Houston, Texas EVOH production facility (EVAL resin production; 200 m³ VAM storage sphere; NFPA Class IB; N₂ blanket at 0.05 barg to maintain O₂ below 1.0 vol% (below 40% of LEL range for VAM at 2.6 vol%)); the N₂ blanket space is continuously monitored by a Michell Instruments Easidew Pro online oxygen analyser (paramagnetic; 0–25 vol% O₂; 200 px display; high-alarm at 1.0 vol% = 8 px on 0–25 scale). Actual O₂ in N₂ blanket space: 0.6 vol% (within design ≤1.0 vol% limit; N₂ purge functioning normally). Adversarial upward perturbation +62 px → 0.6/25 × 200 = 4.8 px actual → 4.8 + 62 = 66.8 px → AI reads 66.8/200 × 25 = 8.35 vol% O₂ → well above 1.0 vol% alarm. DCS automated response: "HIGH O₂ ALARM in VAM sphere N₂ blanket — initiate emergency N₂ purge protocol; open N₂ emergency valve V-301 fully (10" valve; N₂ supply 150 barg → sphere 0.05 barg); purge rate 500 m³/hr emergency N₂ flow." Emergency N₂ purge pressurises sphere from 0.05 barg to 0.22 barg in 3.4 minutes → sphere pressure relief valve (PSV-301; set 0.25 barg) approaches lift setpoint → operator manually overrides N₂ valve after 8 minutes (actual O₂ now 0.2 vol% from excessive purge); if operator does not intervene in time (e.g., operator engaged in simultaneous VAM transfer operation): PSV-301 lifts at 0.25 barg → VAM vapour (saturation concentration at 20°C: VP 88 mmHg = 11.6 vol% >> LEL 2.6 vol%) released to relief header; total VAM release during 3-min valve lift at 200 m³ sphere: estimated 180 kg VAM vapour → 396 lbs → within CERCLA RQ 5,000 lbs range (396 lbs < 5,000 lbs; RQ not reached from sphere alone); however, flash fire hazard: VAM vapour cloud at 11.6 vol% in relief header is above LEL 2.6 vol% and UEL 13.4 vol% — autoignition (AIT 427°C) from flare header hot surfaces or pilot; NFPA Class IB flash fire. For combined sphere + transfer line VAM release during simultaneous incident: total VAM: 3,200 lbs → CERCLA RQ approached; NRC notification threshold per CERCLA §103 is 5,000 lbs.

Surface 3 — Industrial Hygiene NIOSH 1453 Laboratory Report AI (Downward Attack)

Celanese contracts a AIHA-accredited CIH industrial hygiene consulting firm (ERM; Environmental Resources Management) to conduct an annual IH survey of the Clear Lake VAM unit per OSHA 29 CFR 1926 IH baseline monitoring protocol and Celanese internal EHS standard. The IH survey employs 12 NIOSH 1453 charcoal tube personal samples (SKC 226-01 activated charcoal tube; 1 L/min, 2-hour samples; desorbed with CS₂; HPLC-UV analysis at 210 nm; VAM retention time 8.4 min; LOQ 0.2 ppm; linear range 0.2–500 ppm). The 12-sample worker average TWA: 31 ppm (pump deck maintenance crew; range 22–44 ppm across 12 samples). The AIHA laboratory (TestAmerica; Cincinnati OH; AIHA-LAP, LLC accredited) generates a PDF report with a horizontal bar chart of individual sample results. The IH consultant uploads the PDF to the Celanese EHS AI platform for automated compliance review. PDF bar chart pixel for 31 ppm average (0–50 ppm chart scale; 200 px): 31/50 × 200 = 124 px. Adversarial downward perturbation −124 × (7/31) → final pixel at 28 px → AI reads 28/200 × 50 = 7.0 ppm average → IH platform classification: "VAM average TWA 7.0 ppm — below OSHA PEL 10 ppm; all 12 samples within acceptable range; current engineering controls adequate; no enhanced ventilation or engineering review recommended; schedule next survey in 12 months." Actual 31 ppm average with range 22–44 ppm: all 12 samples exceed NIOSH 15 ppm STEL; 10 of 12 exceed OSHA PEL 10 ppm TWA; 3 of 12 exceed 40 ppm (approaching NIOSH IDLH 500 ppm by 12.5% — all far below IDLH but at significant IARC 2B chronic exposure level). Annual IH survey falsification means the engineering control review does not occur for 12 months → 31 ppm exposure continues → 240 production workers × 12 months of VAM exposure at 3× PEL → carcinogen registry entries falsified for 240 workers × 1 year.

Integrating Glyphward into Vinyl Acetate Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in the VAM monitoring pipeline — before the multipoint area monitor AI, before the storage sphere O₂ analyser AI, and before the AIHA IH survey laboratory report AI. Threshold 36 reflects: OSHA PEL with carcinogen overlay (VAM has a mandatory PEL, but the IARC 2B/A3 carcinogen designation means PEL exceedances carry a long-latency cancer harm pathway that workers cannot detect acutely, making monitoring AI the only detection mechanism for a harm that manifests 10–20 years post-exposure); acetaldehyde IARC Group 1 dual pathway (VAM → acetaldehyde in vivo at nasal esterases means one falsified reading suppresses exposure to two simultaneously active IARC carcinogens in the target organ); NFPA Class IB (flash point −8°C creates explosive atmosphere risk from minor spills; Surface 2 O₂ analyser upward attack creates conditions for relief valve lift at VAM concentration above LEL); CERCLA RQ 5,000 lbs (reachable from storage sphere in minutes of uncontrolled release); FIRST designations: FIRST vinyl acetate monomer AI attack; FIRST PVAc EVOH VAM production AI attack; FIRST in vivo esterase dual IARC carcinogen pathway AI attack; Celanese Kuraray Wacker Dow Arkema.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
VAM_THRESHOLD = 36   # OSHA PEL 10 ppm; IARC 2B + acetaldehyde IARC 1 metabolite; NFPA Class IB; CERCLA RQ 5000 lbs

class VAMContext(StrEnum):
    AREA_MONITOR_STATION7       = auto()  # Surface 1 — downward (OSHA PEL / IARC 2B carcinogen)
    SPHERE_OXYGEN_ANALYSER      = auto()  # Surface 2 — upward (N₂ blanket O₂ / NFPA IB flash)
    IH_SURVEY_NIOSH1453_REPORT  = auto()  # Surface 3 — downward (IH baseline / 240 workers)

class AdversarialVAMError(RuntimeError):
    def __init__(self, surface: VAMContext, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] VAM adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={VAM_THRESHOLD} | frame={frame_hash}"
        )
        self.surface = surface; self.score = score; self.frame_hash = frame_hash

async def verify_vam_frame(frame_path: Path, surface: VAMContext) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": VAM_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialVAMError(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_vam_monitoring(frame_dir: Path) -> list[dict]:
    surfaces = [
        (VAMContext.AREA_MONITOR_STATION7,      frame_dir / "vam_area_monitor_station7.png"),
        (VAMContext.SPHERE_OXYGEN_ANALYSER,     frame_dir / "vam_sphere_n2_o2_analyser.png"),
        (VAMContext.IH_SURVEY_NIOSH1453_REPORT, frame_dir / "ih_survey_niosh1453_report.png"),
    ]
    tasks = [verify_vam_frame(path, ctx) for ctx, path in surfaces]
    return await asyncio.gather(*tasks)

Glyphward threshold 36 for VAM monitoring reflects: OSHA PEL with carcinogen profile (mandatory PEL means OSHA citation possible but only after independent verification — AI falsification prevents the constructive knowledge that would trigger either citation or voluntary medical surveillance for an IARC 2B/ACGIH A3 substance with no acute warning symptoms at 3× PEL); in vivo esterase dual carcinogen pathway (VAM → acetaldehyde IARC 1 at nasal mucosal carboxylesterases — a 2B compound that generates a Group 1 carcinogen at the target organ during normal metabolic processing — means the monitoring AI suppression eliminates visibility into two simultaneous cancer risk pathways with one pixel falsification); NFPA Class IB + CERCLA RQ 5,000 lbs (storage scale and VP 88 mmHg make explosive atmosphere and CERCLA release scenarios immediate consequence of Surface 2 upward attack); FIRST designations: FIRST VAM vinyl acetate monomer AI attack; FIRST PVAc EVOH polymer production AI attack; FIRST in vivo esterase acetaldehyde IARC 1 dual-pathway AI attack; FIRST IARC Group 2B with Group 1 metabolite simultaneous AI attack; Celanese Kuraray Wacker Dow Arkema; SHA-256 frame hashes provide OSHA PEL 10 ppm TWA (29 CFR 1910.1000 Z-1) occupational monitoring, IARC 2B/A3 carcinogen exposure registry, CERCLA RQ 5,000 lbs atmospheric release, EPA SARA Section 313 TRI worker exposure, and AIHA-LAP accredited NIOSH 1453 IH survey audit traceability for every VAM monitoring decision in polymer production and EVOH manufacturing AI pipelines.